Approval could come as early as mid-June.
that in a subset of participants in their clinical trial of 1,678 children ages 6 months-4 years, a 3-dose series of the vaccine proved to be 80% effective in preventing symptomatic Covid infection.
This data is preliminary, as only ten Covid cases were reported in subjects enrolled in the study thus far. The data will be analyzed and finalized once there have been 21 cases, as per the clinical trial’s protocol.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
Weiterlesen »
Pfizer covid shot 80 percent effective in young kids, early data showsThe results, along with other recent developments, signal that the long and frustrating wait for a vaccine for the youngest children, the last group to lack access, could be over within weeks.
Weiterlesen »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Weiterlesen »
3 doses of COVID vaccine are effective for kids under 5, Pfizer saysThe long-awaited findings bring the vaccine one step closer to a reality for parents of children ages 6 months to 4 years — the only group that remains ineligible for vaccination.
Weiterlesen »
Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Weiterlesen »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced this morning.
Weiterlesen »